Earnings Summary

Humanigen Inc’s revenue fell -78.67% since last year same period to $0.22Mn in the Q1 2023. On a quarterly growth basis, Humanigen Inc has generated -90.36% fall in its revenue since last 3-months.

Humanigen Inc’s net profit jumped 80.51% since last year same period to $-4.15Mn in the Q1 2023. On a quarterly growth basis, Humanigen Inc has generated 91.18% jump in its net profits since last 3-months.

Humanigen Inc’s net profit margin jumped 8.64% since last year same period to -1876.47% in the Q1 2023. On a quarterly growth basis, Humanigen Inc has generated 8.52% jump in its net profit margins since last 3-months.

Humanigen Inc’s earning per share (EPS) estimates for the current quarter stand at -0.04 - a 77.78% jump from last quarter’s estimates.

Humanigen Inc’s earning per share (EPS) estimates for the current year stand at -0.04.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Humanigen Inc’s return on assets (ROA) stands at -0.85.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Humanigen Inc’s return on equity (ROE) stands at -21.65.